Doctors start prescribing weight-loss drugs to some children

Physicians are prescribing weight-loss medications known as GLP-1s to select pediatric patients in Louisiana and other areas. Dr. Rhea Rogers, a board-certified physician who hosts the television program Aging Untold, confirmed that these drugs, which have become popular among adults, are now entering pediatric care for specific cases. The medication targets obesity that has not responded to standard lifestyle adjustments.

Experts outline strict criteria for prescribing these drugs to children. For patients diagnosed with diabetes, the age requirement for treatment is 10 years and older. For those seeking treatment for weight loss, the ideal candidate has a Body Mass Index at or above the 95th percentile. Medical professionals also require that lifestyle changes alone have failed to produce results before considering pharmacological intervention.

Rogers explained that genetics and hormonal dysregulation often prevent simple dietary changes from working for some children. She noted that when a child becomes significantly overweight, the body can enter a state of hormonal imbalance. In these instances, Rogers said the medications help reduce what she called food noise and food chatter. She also described the drugs as anti-inflammatory, adding that some patients require additional medical support due to these internal changes.

Students at Magnolia Woods Elementary in Baton Rouge, Louisiana, are participating in a statewide push to lower obesity rates. The program focuses on teaching healthy eating habits and exercise routines. This educational effort aims to establish a foundation of health before medical intervention becomes necessary for those who do not respond to behavioral changes.

Rogers emphasized that the medication is a tool rather than a miracle cure. She stated that doctors must treat the entire scenario, including the patient's overall health context. For patients who develop hormone problems requiring medical intervention, the drug serves as one component of a larger treatment plan. The goal is to manage the condition comprehensively rather than relying on a single solution.

Cost remains a primary barrier for many families considering these treatments. For patients who cannot afford the medication or choose not to take it, the current option is maintaining well-balanced meals and a healthy lifestyle. Families must weigh the financial cost against the potential health benefits of the pharmaceutical approach.

The prescribing trends reflect a shift in how doctors view childhood obesity. The combination of genetic factors and modern diets has created a need for medical tools beyond traditional advice. Parents and doctors are now evaluating GLP-1s as a viable option for children who meet specific clinical thresholds.